Hodgkin Lymphoma in Remission

2

Review clinical trials related to Hodgkin Lymphoma in Remission. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of dexrazoxane hydrochloride on cells. It may also help doctors understand how well patients respond to treatment.

Participants needed: 420
Trial details
Biological sex: AllType: ObservationalSponsor: Children's Oncology GroupUpdated: May 18, 2026Locations: 79
Eligibility criteria

STRATUM I AND STRATUM II: LEUKEMIA AND LYMPHOMA SURVIVORS [+10]

Newly diagnosed, previously untreated biopsy-proven moderate or high grade osteo... [+14]

Status: Recruiting

Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma

Study design: It is a monocentric and exploratory study, experimental on human tissues in vitro which involves the analysis of peripheral blood in patients with Hodgkin's lymphomas with the following characteristics: * in complete remission for at least two years after first-line therapy with stage IIb, III or IV at onset (Ann Arbor classification). * newly diagnosed (stage IIb, III or IV, Ann Arbor Classification).

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaUpdated: Jan 7, 2025Locations: 1
Eligibility criteria

hodgkin lymphoma stage II b, III or IV at onset in remission for at least two ye... [+3]

Concomitant second neoplasm